Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area cell cycle c myc'

Search results for: 'research area cell cycle c myc'

Items 11-20 of 28

Page
per page
  1. PD168393
    A2024 PD168393
    Target: PDGFR|FGFR|EGFR|PKC|insulin
    Summary: EGFR inhibitor
  2. SD 1008
    A4515 SD 1008
    Summary: Inhibitor of JAK2/STAT3 signaling pathway,apoptosis inducer
      <32.94 mg/mL
  3. Gefitinib hydrochloride
    A3433 Gefitinib hydrochloride
    Target: EGFR
    Summary: Potent EGFR inhibitor
      insoluble in EtOH; ≥4.28 mg/mL
  4. Erlotinib Hydrochloride
    A8234 Erlotinib Hydrochloride
     2 Citation
    Summary: Selective EGFR inhibitor
      insoluble in H2O; insoluble in EtOH; ≥6.44 mg/mL
  5. AG-1478
    A8357 AG-1478
    Target: EGFR
    Summary: EGFR inhibitor,potent and selective
      insoluble in H2O; ≥15.8 mg/mL
  6. JAK2 Inhibitor V, Z3
    A3514 JAK2 Inhibitor V, Z3
    Summary: Jak2 tyrosine kinase inhibitor
      Soluble in DMSO or ethanol
  7. AZD-9291 mesylate
    B1105 AZD-9291 mesylate
    Summary: third generation EGFRm inhibitor, oral and irreversible
      insoluble in EtOH; insoluble in DMSO; insoluble in H2O
  8. Baricitinib (LY3009104, INCB028050)
    A4141 Baricitinib (LY3009104, INCB028050)
     2 Citation
    Summary: JAK1/JAK2 inhibitor,selective orally bioavailable
      insoluble in EtOH; insoluble in H2O; ≥18.57 mg/mL
  9. Neratinib (HKI-272)
    A8322 Neratinib (HKI-272)
     1 Citation
    Target: EGFR
    Summary: HER2/EGFR inhibitor,potent and irreversible
      insoluble in H2O; ≥13.93 mg/mL
  10. TCS-PIM-1-4a
    B4764 TCS-PIM-1-4a
    Summary: Pim inhibitor

Items 11-20 of 28

Page
per page